SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Hand holding a pill against psychedelic background
Opinion
Fixing the IRA’s Pill Penalty Is Critical to Supporting Small Molecule Innovation
Price-negotiation provisions that are out of step with reality are discouraging funders and Big Pharma partners from investing in potentially transformative therapies. Fixing some of the unintended consequences of the IRA will clear the way for innovative medicines to reach patients in need.
February 25, 2025
 · 
6 min read
 · 
Thomas M. Kaiser
The court's decision cancels all agreements. Agreement between the parties to the dispute. Conflict resolution in court.
COVID-19
FDA Shoots Down Invivyd’s Bid to Expand EUA for COVID-19 Antibody
Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent requirements for antibody activity boxed out its potential use as a post-exposure treatment.
February 24, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Anatomical model of human ear with luminous sound wave on blue background. Auditory health.
Gene therapy
Regeneron’s Gene Therapy Restores Hearing in Patients with Rare Genetic Condition
The treatment, called DB-OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic deafness.
February 24, 2025
 · 
4 min read
 · 
Dan Samorodnitsky
seamless pattern with infusoria slipper and ameba in vector. Template for design, print, background, packaging, book, wrapping paper, fabric.world series.
Infectious disease
Small Harvard Start-Up Launches to Fight Huge Problem of Antimicrobial Resistance
The World Health Organization names antimicrobial resistance as one of the most urgent public health threats, but it remains an unattractive target for the pharmaceutical industry due to its weak profitability.
February 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Successful businessman standing on the building looking down and man looking up, which pointing up as symbol of achievement, success and developing business in successful way
Government
Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.
February 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Minimal Clip Art Collage. Pop Vector Design Composition with bright bold geometric shapes, halftone objects for ad, animation etc
Approvals
Mirum Establishes Liver Expertise With First FDA Nod for ‘Very Rare’ Disease
Ctexli’s approval further entrenches Mirum as a leader in rare liver diseases, alongside its cornerstone product Livmarli and upcoming drug volixibat.
February 24, 2025
 · 
2 min read
 · 
Tristan Manalac
3d rendering robot hand holding newton cradle
Drug Development
Opinion: AI Is Pushing the I&I Pendulum From Biologics to Small Molecules
Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making small molecules more attractive in the complex inflammatory & immunology disease space.
February 24, 2025
 · 
6 min read
 · 
Christian Antoni
FDA signage at its headquarters in Maryland
Government
FDA to Rehire Scientists After Trump’s Firing Spree: Reuters
Around 300 FDA staffers laid off last week are being asked to return. So far, the Trump administration has terminated some 1,000 employees from the agency.
February 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Composite artwork collage image picture of knives inside wall cover mini sad girl isolated on creative background.
Pain
Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids Here to Stay
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a growing number of alternative approaches. Their ultimate uptake, however, remains to be seen.
February 24, 2025
 · 
9 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS